Biolidics – Bringing clarity to cancer Biolidics Ltd, formerly known as Clearbridge BioMedics, is a medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. Biolidics has developed patented technology and solutions with the potential to serve as a platform technology for the diagnosis, prognosis, treatment selection and treatment monitoring of various types of cancers. The ClearCell® FX1 System by Biolidics is a fully automated CE-IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patient's body. Our patented award-winning microfluidic technologies have many applications throughout the various stages of a patient's cancer journey, from cancer screening and staging to personalised treatment, and post-cancer monitoring. The ClearCell® FX1 System has been installed in academic and research institutes, hospitals and laboratories across the world, including Singapore, China, Hong Kong, Japan, the US and certain EU countries. Biolidics is a spin-off from the National University of Singapore (NUS) / SMART MIT and is the first incubatee of Clearbridge Accelerator, a high-technology incubator backed by the Singapore Government’s National Research Foundation (NRF). For more information, please visit www.biolidics.com.
View Top Employees from Biolidics Limited (Formerly known as Clearbridge BioMedics)Website | http://www.biolidics.com/ |
Revenue | $18 million |
Employees | 25 (21 on RocketReach) |
Founded | 2009 |
Address | The Chadwick, 81 Science Park Dr., #02-03, Singapore, Central Singapore, SG |
Phone | (656) 482-0668 |
Technologies |
HTML,
reCAPTCHA,
Bootstrap
+3 more
(view full list)
|
Industry | Medical Equipment Manufacturing, Medical Testing & Clinical Laboratories, Biotechnology, Healthcare, Drug Discovery |
SIC | SIC Code 807 Companies, SIC Code 80 Companies, SIC Code 8071 Companies |
NAICS | NAICS Code 62 Companies, NAICS Code 621 Companies |
Looking for a particular Biolidics Limited (Formerly known as Clearbridge BioMedics) employee's phone or email?
The Biolidics Limited (Formerly known as Clearbridge BioMedics) annual revenue was $18 million in 2024.
c.a Han Seung Hue is the Director of Biolidics Limited (Formerly known as Clearbridge BioMedics).
21 people are employed at Biolidics Limited (Formerly known as Clearbridge BioMedics).
Biolidics Limited (Formerly known as Clearbridge BioMedics) is based in Singapore, Central Singapore.
The NAICS codes for Biolidics Limited (Formerly known as Clearbridge BioMedics) are [62, 621].
The SIC codes for Biolidics Limited (Formerly known as Clearbridge BioMedics) are [807, 80, 8071].